OVA-T4 Peptide, SIITFEKL, pT4, OVA (257-264) Variant contains a threonine substitution at position 4, subtly reshaping the epitope’s hydrogen-bonding network. Its sequence supports detailed analysis of anchor flexibility and MHC pocket adaptation. Researchers employ it in T-cell recognition studies alongside canonical SIINFEKL. The peptide aids high-resolution mapping of OVA variant structure–activity relationships.
CAT No: O05025
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More